Arjan W. Griffioen
- Cancer Research top 0.2%
- Cancer, Hypoxia, and Metabolism 34
- Immunology top 0.2%
- Galectins and Cancer Biology 27
- Immunology and Allergy top 0.2%
- Cell Adhesion Molecules Research 43
- Oncology top 0.2%
- Peptidase Inhibition and Analysis 14
- Molecular Biology top 0.2%
- Angiogenesis and VEGF in Cancer 113
- Glycosylation and Glycoproteins Research 23
-
- Nanoplatforms for cancer theranostics 15
-
- Monoclonal and Polyclonal Antibodies Research 14
- Co-authors
- Victor L. ThijssenJudy R. van BeijnumGrietje MolemaPatrycja Nowak‐SliwinskaKevin H. MayoWillem J. M. MulderKlaas NicolayGustav J. Strijkers
- Journals
- Angiogenesis (25 papers)Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (17 papers)Cancer Research (8 papers)
- Partner nations
- NetherlandsUnited StatesSwitzerland
In The Last Decade
Arjan W. Griffioen
277 papers receiving 19.1k citations
Hit Papers
Peers
Comparison fields: 5 of 162
- Cancer Research 3.6k
- Immunology 4.7k
- Immunology and Allergy 1.3k
- Oncology 5.4k
- Molecular Biology 10.1k
Countries citing papers authored by Arjan W. Griffioen
This map shows the geographic impact of Arjan W. Griffioen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arjan W. Griffioen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arjan W. Griffioen more than expected).
Fields of papers citing papers by Arjan W. Griffioen
This network shows the impact of papers produced by Arjan W. Griffioen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arjan W. Griffioen. The network helps show where Arjan W. Griffioen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Arjan W. Griffioen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 6 | |
| 2 | 2023 | 7 | |
| 3 | 2022 | 1 | |
| 4 | 2021 | 13 | |
| 5 | 2021 | 15 | |
| 6 | 2016 | 28 | |
| 7 | 2012 | 125 | |
| 8 | 2011 | 290 | |
| 9 | 2011 | 59 | |
| 10 | 2010 | 36 | |
| 11 | 2010 | 193 | |
| 12 | 2010 | 32 | |
| 13 | 2007 | 113 | |
| 14 | 2006 | 129 | |
| 15 | 2006 | 40 | |
| 16 | Clinical and immunohistochemical analysis of patients with unknown primary tumour. A search for prognostic factors in UPT. | 2004 | 38 |
| 17 | Synergy between angiostatin and endostatin | 2000 | 7 |
| 18 | 1998 | 3 | |
| 19 | 1998 | 42 | |
| 20 | CD44 splice variants: expression during lymphocyte activation and tumor progression. | 1993 | 17 |
About Arjan W. Griffioen
Arjan W. Griffioen is a scholar working on Immunology and Allergy, Cancer Research and Immunology, having authored 281 papers that have together received 19.3k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (113 papers), Cell Adhesion Molecules Research (43 papers), Cancer, Hypoxia, and Metabolism (34 papers), Galectins and Cancer Biology (27 papers), Glycosylation and Glycoproteins Research (23 papers), Nanoplatforms for cancer theranostics (15 papers), Peptidase Inhibition and Analysis (14 papers) and Monoclonal and Polyclonal Antibodies Research (14 papers). The work is most often cited by research in Cancer Research (3.6k citations), Immunology (4.7k citations) and Immunology and Allergy (1.3k citations). Arjan W. Griffioen has collaborated with scholars based in Netherlands, United States and Switzerland. Frequent co-authors include Victor L. Thijssen, Judy R. van Beijnum, Grietje Molema, Patrycja Nowak‐Sliwinska, Kevin H. Mayo, Willem J. M. Mulder, Klaas Nicolay, Gustav J. Strijkers, Mirjam G.A. oude Egbrink and Femke Hillen. Their work appears in journals such as Angiogenesis, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, Cancer Research, Cancers and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.